If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDaniel Stewart Securities Plc Regulatory News (DAN)

  • There is currently no data for DAN

DANIEL STEWART RESEARCH ARM CONTINUES TO EXCEL

3 Jun 2009 07:00

RNS Number : 2283T
Daniel Stewart Securities PLC
03 June 2009
 



June 2009

DANIEL STEWART SECURITIES PLC

(AIM)

("Daniel Stewart"," the Group" or "the Company")

DANIEL STEWART RESEARCH ARM CONTINUES TO EXCEL

Pharmaceuticals analyst provides shot in the arm as stock picks rocket

The Board of Daniel Stewart Securities plc is pleased to announce that Vadim Alexandre, a member of staff of Daniel Stewart & Company plcthe Group's investment subsidiary which offers corporate advisory and institutional stockbroking services with a focus on small and mid-sized companieshas been named top Pharmaceuticals and Biotechnology analyst by Shares Magazine in its 2009 awards.

Vadim's winning pick was Asterand plcwhose share price has increased nearly 300% since it was first recommended in May of last year. Vadim's expert stock picking has helped to cement Daniel Stewart's reputation as a leading broker in the Healthcare sector. Recently published Hemscott data ranks Daniel Stewart third in the Healthcare arena by number of clients.

New Hires

As announced on June 2009 Christian Wiss joined Daniel Stewart as Head of Sales. Christian was previously with Neue Zurcher Bank where he was in Market Sales / Research specialising in Financials, Biotech and Pharma stocks. Prior to that, he worked in sales and research for Fox-Pitt and Dresdner Kleinwort Wasserstein.

Stephen Roberts, Head of Corporate Finance, commenced work at Daniel Stewart on 5 May 2009 and has extensive experience having previously held senior positions at Fairfax IS plc, Collins Stewart plc and Evolution Securities plc.

Daniel Stewart continues to focus on providing strong sector-based research expertise and has recently hired Oil &Gas analyst Leila Reddy who was previously at Libertas Capital and, prior to that, at Banard Jacobs Mellet Securities in Johannesburg

Peter Shea, Chief Executive of Daniel Stewart says:

"We are delighted that our research team continues to prove itself. We believe strongly in providing sectoral expertise and analysis and this strategy is really paying dividends. 

"Earlier this year we announced an agreement for the distribution of our research into the United States confirming the outstanding quality of our research product. I see plenty more opportunity to tap into the American market in the coming months.

Enquiries, please contact:

Daniel Stewart & Company plc

Peter Shea Tel: 020 7776 6550

Bishopsgate Communications Ltd.

Maxine Barnes/Nick Rome Tel: 020 7562 3350

Notes to Editors:

About Daniel Stewart

Daniel Stewart Securities is an AIM-listed company providing a range of investment banking services to Small Cap publicly traded and non-publicly traded companies. The Group has two subsidiaries, Daniel Stewart and Company, the Group's principal operating subsidiary, which is authorised and regulated by the Financial Services Authority and is a member of the London Stock Exchange, and Daniel Stewart Capital, the Group's leasing and debt financing division.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAELLFBKQBBBBB
Date   Source Headline
20th Jan 20164:06 pmRNSHolding(s) in Company
19th Jan 20162:47 pmRNSHolding(s) in Company
15th Jan 20165:29 pmRNSUpdate on Suspension
30th Dec 20152:56 pmRNSUnaudited Interim Results
29th Dec 20155:59 pmRNSAppointment of Non-Executive Chairmam
24th Dec 201511:35 amRNSIssue of Equity - Conversion of Bond
21st Dec 20152:42 pmRNSUpdate on Suspension and resignation of Nomad
14th Dec 201510:02 amRNSDirectorate Change
17th Nov 20151:28 pmRNSIssue of Convertible Bonds
11th Nov 20151:20 pmRNSUpdate on Placing
6th Nov 20154:38 pmRNSHolding(s) in Company
2nd Nov 20157:00 amRNSDirectorate Change
23rd Oct 201512:02 pmRNSSuspension Update
1st Oct 20157:30 amRNSSuspension - Daniel Stewart Securities plc
1st Oct 20157:00 amRNSStatement re. Suspension
28th Sep 20155:21 pmRNSUpdate re: FY 2015 Results
22nd Sep 20155:11 pmRNSChange of Registered Office
10th Jul 20157:00 amRNSNon-Executive Director Appointed
25th Jun 20159:46 amRNSSubscription to raise £1.2million
16th Jun 201510:32 amRNSStatement re share price rise
11th May 20157:30 amRNSRestoration - Daniel Stewart Securities Plc
8th May 20154:49 pmRNSNomad appointed and trading to resume
1st May 20158:00 amRNSStatement re. Suspension
1st May 20157:30 amRNSSuspension - Daniel Stewart Securities Plc
23rd Apr 201511:57 amRNSHolding(s) in Company
17th Apr 201510:46 amRNSHolding(s) in Company
17th Apr 201510:44 amRNSHolding(s) in Company - replacement
17th Apr 20157:00 amRNSResignation of Nominated Adviser
16th Apr 20154:38 pmRNSIssue of Equity - Conversion of Epsilon Bond
16th Apr 20154:35 pmRNSHolding(s) in Company
15th Apr 20157:00 amRNSTrading and Business update
9th Apr 201511:28 amRNSResult of AGM
1st Apr 201512:50 pmRNSHolding(s) in Company
31st Mar 20152:33 pmRNSHolding(s) in Company
31st Mar 20151:54 pmRNSStmnt re Share Price Movement
6th Mar 20159:15 amRNSRestoration - Daniel Stewart Securities Plc
6th Mar 20159:05 amRNSRestoration of Listing
6th Mar 20157:00 amRNSAnnual Financial Report and Notice of AGM
29th Jan 20157:00 amRNSFundraising and Regulatory Capital Resolution
23rd Dec 20143:36 pmRNSHalf Year Results
22nd Dec 20143:56 pmRNSUnaudited Preliminary Results
12th Dec 20143:58 pmRNSResponse to Press Speculation and Update
28th Nov 20144:00 pmRNSNominated Adviser licence
6th Nov 201412:48 pmRNSResult of GM and Update on Suspension
14th Oct 20147:00 amRNSCircular and Notice of General Meeting
7th Oct 20143:59 pmRNSUpdate re Suspension
1st Oct 20147:30 amRNSSuspension - Daniel Stewart Securities Plc
1st Oct 20147:00 amRNSShare Suspension
1st Aug 20143:20 pmRNSRe Order Book for Retail Bonds
9th Jul 20147:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.